GlassScriptPhysician profile
Siddhartha Rath
NPI 1255541504
$19,455.01
in general payments reported to CMS, 2019-2025
11 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $14.87 · 2021: $17K · 2022: $1,146 · 2023: $772 · 2024: $95.52 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $701 · Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $701.40 |
| Food and Beverage | $271.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,101.86 | 2019-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $4,039.22 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $100.01 | 2019 | |
| W. L. Gore & Associates, INC. | $45.68 | 2022 | |
| Braintree Laboratories, INC. | $35.76 | 2021 | |
| Conmed Corporation | $28.17 | 2025 | Airseal, Conmed Specimen Retrieval |
| Pacira Pharmaceuticals Incorporated | $28.16 | 2019 | |
| Ethicon US, LLC | $25.21 | 2022 | |
| Baxter Healthcare | $21.91 | 2024 | Tisseel |
| Davol INC. | $15.47 | 2021 | |
| Kerecis Limited | $13.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Siddhartha Rath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.